Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Century Therapeutics Inc

IPSC
3,13
-0,12 (-3,69%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/6/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202422:19EDGAR2Form 144 - Report of proposed sale of securities
03/6/202413:13EDGAR2Form 8-K - Current report
03/6/202413:00GLOBECentury Therapeutics Presents Interim Results from Phase 1..
22/5/202414:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/5/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202418:22EDGAR2Form 144 - Report of proposed sale of securities
15/5/202422:06EDGAR2Form S-3 - Registration statement under Securities Act of..
10/5/202413:00GLOBECentury Therapeutics Presents Preclinical Data Highlighting..
09/5/202413:35EDGAR2Form 8-K - Current report
09/5/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:30GLOBECentury Therapeutics Reports First Quarter 2024 Financial..
07/5/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202422:52EDGAR2Form 144 - Report of proposed sale of securities
23/4/202413:00GLOBECentury Therapeutics to Present at Chardan’s 8th Annual..
11/4/202413:00GLOBECentury Therapeutics Strengthens Position in Autoimmune..
08/4/202422:05GLOBECentury Therapeutics Presents New Preclinical Data..
25/3/202412:00GLOBESagimet Biosciences Announces Appointment of Tim Walbert and..
19/3/202412:00GLOBECentury Therapeutics to Present at the H.C. Wainwright 2nd..
14/3/202412:30GLOBECentury Therapeutics Reports Full Year 2023 Financial..
09/3/202400:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:40EDGAR2Form 144 - Report of proposed sale of securities
06/3/202422:19EDGAR2Form 144 - Report of proposed sale of securities
06/3/202400:03GLOBECentury Therapeutics Announces Six Upcoming Poster..
21/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202419:04EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
16/2/202422:18EDGAR2Form 144 - Report of proposed sale of securities
07/2/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:25EDGAR2Form 144 - Report of proposed sale of securities
05/2/202421:23EDGAR2Form 144 - Report of proposed sale of securities
01/2/202413:00GLOBECentury Therapeutics to Present at the Guggenheim Healthcare..
19/1/202423:03EDGAR2Form 8-K - Current report
11/12/202316:30EDGAR2Form 8-K - Current report
09/12/202318:00GLOBECentury Therapeutics Presents Initial Data from CNTY-101..
06/12/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202322:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/12/202313:46EDGAR2Form 8-K - Current report
06/12/202313:30GLOBECentury Therapeutics Receives FDA Clearance of IND..
21/11/202313:00GLOBECentury Therapeutics to Present at the Piper Sandler 35th..
09/11/202313:56EDGAR2Form 8-K - Current report
09/11/202313:01GLOBECentury Therapeutics Reports Third Quarter 2023 Financial..
09/11/202313:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:00GLOBECentury Therapeutics and FUJIFILM Cellular Dynamics Announce..
03/11/202321:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202314:00GLOBECentury Therapeutics to Present Initial Clinical Data..
03/10/202314:00EDGAR2Form 8-K - Current report
Apertura: 3,22 Min: 3,10 Max: 3,30
Chiusura: 3,25

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network